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404 Are there any sex differences in lung function of CFTR – knock
out mice?
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Cystic ﬁbrosis is the most prevalent lethal autosomal recessive disorder in Cau-
casians. Various organs are affected; however, death commonly results from pro-
gressive lung disease. We studied lung function (Reinhard, Mamm. Genome 2002)
in 14 week old Cftrtm1HGU mice (−/− and +/−) and non-CF controls (+/+, Charles
River, UK) raised under SPF-conditions so that the animals had no bacterial
colonization of the lungs. There was no effect on body weight (bw)in cftr mice
when compared to wt, but bw were about 30% higher in male mice (29.5±3 g
vs. 22±2 g in −/− mice). Despite these differences in bw, total lung capacity
(TLC), as an index for lung size, was comparable between sexes (1.3±0.1 and
1.18±0.1 ml in % and & −/− mice) indicating that speciﬁc TLC is higher in &.
Both sexes of the cftr mutants exhibited a little smaller TLC than wild types (<5%,
ns). Series dead space volume was not affected by the mutation (0.23±0.01ml
and 0.22±0.01ml in % + & −/− mice). Compliance values of the lung tended to
be smaller in mutants (e.g., in &: 57±7ml/cmH2O in −/−, 64±11ml/cmH2O in
+/− and 71±16ml/ cmH2O in +/+ mice), but differences failed to be statistically
signiﬁcant. Gas exchange, assessed by pulmonary diffusing capacity for carbon
monoxide, showed no genotype speciﬁc differences but signiﬁcant sex differences
in cftr mice (15±1.6mmol/min/hPa and 12±1.5mmol/min/hPa in % and & −/−
mice). In summary, respiratory function exhibits distinct sex speciﬁc differences
in mutants but genotype speciﬁc sig. differences were not detectable in uninfected
14 week old mice. There may be trend for deviation from reference values from
control suggesting that a limited lung function may develop with age.
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The content and water (H2O) mobility in airway epithelium is tighly coupled to
airway function. In cystic ﬁbrosis (CF), H2O epithelial permeability is reduced
in airways. The demand of noninvasively imaging techniques with high spatial
resolution potential is rising because such imaging tools would expedite anatomical
and functional phenotyping in the genetically altered mice. Magnetic resonance
microscopy (MRM) is a noninvasive, inherently three-dimensional (3D) imaging
technique capable of visualizing anatomical structures in the mouse and allows
for interpretation of complex spatial relationships between substructures and H2O.
In this study, we explore different MR contrast parameters and signal-to-noise
ratios at a 30mm pixel size to characterize microstructure and H2O mobility in
ex vivo trachea of CF transmembrane conductance regulator (CFTR)-deﬁcient
(CFTR knockout, Cftr tm1UNC) mice and their aged-matched WT littermates. This
study is performed using a Bruker MRM system at 11.7 tesla. We demonstrate
for the ﬁrst time the ability of 3D-MRM to map the H2O content and mobility
in trachea epithelium. From the 3D-MRM video-images, differential H2O content
was visualized in different levels of trachea in WT and CF mice. T2 MRM images
depicting the H2O rotational mobility which is related to environmental viscosity
of trachea epithelium will be shown. Finally, this 3D-MRM imaging method is
a valuable method for measuring H2O permeability in airways and can serve for
assessing the effects of drugs on H2O mobility in CF airways.
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